ABGD

HIGHMARK AND UNITED CONCORDIA DENTAL TO PROVIDE FREE ONSITE DENTAL SERVICES IN UNDERSERVED PA COMMUNITIES

Retrieved on: 
Friday, June 9, 2023
ABGD, Mouth, Highmark, Fear, Research, Mile, Dental hygienist, Dentist, The New York Times, Patient, Dentistry, Pennsylvania Office of General Counsel, DDS, Dental care, Health, Hunger, Dental, City, Allegheny Health Network, Health insurance, Ageing, WellSpan Health

PITTSBURGH, June 9, 2023 /PRNewswire/ -- Highmark Inc. and Highmark Wholecare are major sponsors of United Concordia Dental's mobile dental tours providing free onsite dental services — including exams, cleanings and fluoride treatments — to underserved communities throughout Pennsylvania this summer. These mobile dental tours are intended to address health access concerns for pediatric, young adult and senior Pennsylvanians.

Key Points: 
  • Three summer mobile dental tours will crisscross Pennsylvania caring for more than 1,000 children, young adults and senior Pennsylvanians
    PITTSBURGH, June 9, 2023 /PRNewswire/ -- Highmark Inc. and Highmark Wholecare are major sponsors of United Concordia Dental's mobile dental tours providing free onsite dental services — including exams, cleanings and fluoride treatments — to underserved communities throughout Pennsylvania this summer.
  • The mobile dental unit uses volunteer dentists and dental hygienists from United Concordia's network to provide an array of dental services, including oral cancer screenings.
  • If additional care is needed in additional to onsite services, referrals will be provided.
  • "We are pleased Highmark, Inc., and Highmark Wholecare are sponsoring the Healthy Smiles tours for communities across Pennsylvania to help residents in need be their healthiest."

Study Published in "Military Medicine" Reports 88% Success Treating Obstructive Sleep Apnea Patients with Precision Oral Appliance Therapy

Retrieved on: 
Thursday, December 8, 2022
Choking, Heart failure, Intellectual property, Patient, Register, Entrepreneurship, Health, Failure, Somnolence, MS, Dentist, Hypertension, DMD, Continuous positive airway pressure, Security (finance), Food, Marketing, Obstructive sleep apnea, Record, REM, Regulation of tobacco by the U.S. Food and Drug Administration, Stroke, Rapid eye movement sleep, Press release, Form, Respiratory disturbance index, Form 10-K, CPAP, Military medicine, Sleep, Defense, Lakeshore, OAT, Research, Carl, ABGD, Risk, COVID-19, Defense Health Agency, Pharmaceutical industry

SAN FRANCISCO, Dec. 08, 2022 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the publication of a peer-reviewed, independent, study in Military Medicine, in which 88% of patients with Obstructive Sleep Apnea (“OSA”) were successfully treated using the Company’s novel precision intraoral medical devices. Following approval from the Carl R. Darnall Army Medical Center Institutional Review Board and the Defense Health Agency, the investigators analyzed the records of active-duty military patients treated for OSA to determine the success of precision oral appliance therapy (“OAT”) based on a symptom-driven titration.

Key Points: 
  • “Sleep is an incredibly important factor in one’s overall health and daily performance, so we are especially interested in ways to improve soldiers’ rest.
  • Our primary goal was to evaluate if OSA can be effectively managed with Precision OAT.
  • The study also reported statistically significant improvements in respiratory disturbances (“RDI”), oxygen saturation, REM sleep, sleep efficiency and daytime sleepiness, with a 79.6% mean reduction in sleep apnea events.
  • With more than 150,000 patients treated, ProSomnus’ devices are the most prescribed Precision Oral Appliance Therapy in the U.S. To learn more, visit www.ProSomnus.com .